1Professor department of Mathematics, St. Martin’s Engineering College, Secunderabad, Telangana, PIN-500100, ranadheer.phdku@gmail.com
2Ph.D Scholar, Commerce, KPR College of Arts Science and Research, Coimbatore, Tamil Nadu, andreavarghese@kprcas.ac.in
3Associate Professor, Electronics and Communication Engineering, Sreenidhi Institute of Science and Technology, Medchal-Malkajgiri, Hyderabad, Telangana, pamuleti.c@sreenidhi.edu.in
4Assistant professor, Department Of CSE, adusumalli7ahb@gmail.com. CVR COLLEGE OF ENGINEERING Ranga Reddy, Hyderabad, Telangana
5Faculty of Commerce & Management, Marketing, r.shridhar@kalingauniversity.ac.in
6Director, Array Research Pvt Ltd, 7505264391akg@gmail.com
Stimuli-responsive drug delivery platforms represent an advanced class of therapeutic systems designed to release drugs in response to specific internal or external biological triggers. Conventional drug delivery methods often suffer from limitations such as non-specific distribution, systemic toxicity, rapid drug degradation, and inefficient therapeutic concentration at target sites. Stimuli-responsive delivery systems overcome these challenges by enabling controlled and site-specific drug release based on environmental signals such as pH variation, temperature changes, enzyme activity, redox potential, magnetic fields, light exposure, and ultrasound stimulation. These smart delivery platforms utilize advanced nanomaterials including polymeric nanoparticles, hydrogels, liposomes, dendrimers, and inorganic nanostructures that can dynamically respond to physiological or externally applied stimuli. By incorporating responsive components into drug carriers, therapeutic agents can remain stable during circulation and release only when the appropriate biological trigger is encountered. This targeted release mechanism significantly improves drug bioavailability, enhances therapeutic efficacy, and reduces adverse side effects. In recent years, extensive research has focused on the design strategies of stimuli-responsive nanocarriers capable of responding to tumor microenvironment conditions such as acidic pH, hypoxia, and enzyme overexpression. External stimulus-controlled systems have also been developed to allow clinicians to precisely regulate drug release using light irradiation, magnetic fields, or thermal activation. These technologies have demonstrated promising results in the treatment of complex diseases including cancer, inflammatory disorders, cardiovascular diseases, and neurological conditions. Furthermore, the integration of advanced biomaterials with nanotechnology has enabled the development of multifunctional platforms capable of combining therapeutic delivery with diagnostic imaging and real-time monitoring of treatment response. This study explores the design strategies, mechanisms, and therapeutic applications of stimuli-responsive drug delivery platforms. The research analyzes various stimulus-responsive materials, evaluates their drug release mechanisms, and examines their clinical potential in improving targeted therapy. The findings highlight the significant role of smart drug delivery systems in advancing precision medicine and next-generation biomedical therapies.
Keywords: Stimuli-Responsive Drug Delivery, Smart Nanocarriers, Targeted Therapeutics, Controlled Drug Release, Nanomedicine, Biomedical Engineering
How to cite this article: Donthi R, Varghese A, Pamuleti C, Himabindu A, Shridhar R, Garg A. Stimuli-Responsive Drug Delivery Platforms Design Strategies and Therapeutic Applications. Int J Drug Deliv Technol. 2026; 16(8s): 315-324; DOI: 10.25258/ijddt.16.8s.43
Source of support: Nil.
Conflict of interest: None